www.fdanews.com/articles/153147-critical-pharmaceuticals-announces-successful-completion-of-second-clinical-trial-on-cp024-intranasal-growth-hormone

Critical Pharmaceuticals Announces Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone

February 12, 2013

Critical Pharmaceuticals today announced that it has successfully completed a second clinical study on its CP024 growth hormone nasal spray.
PipelineReview